Caliper Life Sciences forms SAB to develop additional solutions for next generation sequencing workflows

NewsGuard 100/100 Score

Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.

"Although tremendous advances have been made in next and third generation sequencing instrumentation and informatics, there remains an unmet need for high quality sample preparation techniques," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences. "We are working with the world renowned members of our Sequencing Advisory Board to identify opportunities that improve sequencing workflows while leveraging Caliper's extensive microfluidics IP estate.  We continue to assess strategic opportunities to directly commercialize products and to out-license our microfluidic technology to collaborators."

Caliper's Sequencing Scientific Advisory Board (SAB) includes the following experts:

Dr. Michael Quail, Wellcome Trust Sanger Institute

Dr. Vincent Magrini, Washington University Genome Sequencing Center

Dr. Patrick Cahill, The Broad Institute of MIT and Harvard

Dr. Christopher Detter, U.S. Department of Energy - Joint Genome Institute

Dr. Jan Fang Cheng, U.S. Department of Energy - Joint Genome Institute

Mr. John Gill, J. Craig Venter Institute

Mrs. Karen Beeson, J. Craig Venter Institute

Several Caliper solutions for next generation sequencing will be presented next week at Advances in Biology and Genomic Technologies (AGBT) in Marco Island, Florida.  Caliper Life Sciences will introduce an Early Access Innovators program for the LabChip XT and will showcase automation and high throughput separation solutions, as well as the fractionation instrument.  For additional information, please visit http://www.caliperLS.com

Source:

Caliper Life Sciences, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research explores the health benefits of resistant starch in plant-based diets